Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

An Innovative Standard Operation Procedure for Isolating GMP-Grade CD4+CD25+ T Cells from Non-Mobilized Leukapheresis.

Zhang W. et al, (2019), Methods Mol Biol, 1899, 67 - 83

PLACENTAL CAPILLARY PERICYTES RELEASE MORE EXOSOMES AND IMMUNOMODULATORY AND GROWTH FACTORS IN RESPONSE TO HYPOXIA

Motta-Mejia C. et al, (2018), PLACENTA, 69, E75 - E76

An innovative method to generate a Good Manufacturing Practice–ready regulatory T-cell product from non-mobilized leukapheresis donors

Zhang W. et al, (2015), Cytotherapy, 17, 1268 - 1279

High Proportions of Regulatory T Cells in Peripheral Blood Stem Cell Grafts Are Associated with Improved Total Lymphocyte, CD8(+) T Cell and CD19(+) Cell Recovery Following Allogeneic Haematopoietic Stem Cell Transplantation

Danby RD. et al, (2014), BLOOD, 124

Ex Vivo Expanded Human Regulatory T Cells Can Prolong Survival of a Human Islet Allograft in a Humanized Mouse Model

Wu DC. et al, (2013), Transplantation Journal, 96, 707 - 716

Selective depletion of FOXP3high cells by Fas–Fas-L–induced apoptosis occurs in CD4+CD25+-enriched populations during repeated expansion

Zhang W. et al, (2013), Cytotherapy, 15, 1286 - 1296

Serum cytokine levels early post-allogeneic haematopoietic stem cell transplant are predictors of GvHD and survival

Danby R. et al, (2013), BONE MARROW TRANSPLANTATION, 48, S412 - S412

Low numbers of regulatory T-cells (% CD4 T-cells) within the haematopoietic stem scll graft are associated with poor engraftment and worse overall survival following allogeneic haematopoietic stem cell transplantation

Danby R. et al, (2012), BONE MARROW TRANSPLANTATION, 47, S305 - S305

Production of TNF alpha discriminates activated human Th cells from Treg cells

Zhang W. et al, (2011), BRITISH JOURNAL OF HAEMATOLOGY, 153, 68 - 68

Treg GMP isolation for clinical trial in haematopoietic stem cell transplantation: lessons and experience

Zhang W. et al, (2011), BRITISH JOURNAL OF HAEMATOLOGY, 153, 68 - 68

In vivo prevention of transplant arteriosclerosis by ex vivo–expanded human regulatory T cells

Nadig SN. et al, (2010), Nature Medicine, 16, 809 - 813

Ex vivo expansion of regulatory T-cells is enhanced by the inhibition of Fas-induced apoptosis

Zhang W. et al, (2010), BONE MARROW TRANSPLANTATION, 45, S324 - S324

Evidence for the Specificity for Platelet HPA-1a Alloepitope and the Presenting HLA-DR52a of Diverse Antigen-Specific Helper T Cell Clones from Alloimmunized Mothers

Rayment R. et al, (2009), The Journal of Immunology, 183, 677 - 686

329: Ex Vivo Expanded Human Treg Inhibit the Development of Transplant Arteriosclerosis in a Humanized In Vivo Model

Nadig SN. et al, (2008), The Journal of Heart and Lung Transplantation, 27, S179 - S179

Scenarios for Autoimmunization of T and B Cells in Myasthenia Gravis

SHIONO H. et al, (2003), Annals of the New York Academy of Sciences, 998, 237 - 256

Spontaneous production of anti-IFN- and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor

Shiono H., (2003), International Immunology, 15, 903 - 913

Circulating regulatory anti–T cell receptor antibodies in patients with myasthenia gravis

Jambou F. et al, (2003), Journal of Clinical Investigation, 112, 265 - 274

Autoantibodies to IL-12 in myasthenia gravis patients with thymoma; effects on the IFN-γ responses of healthy CD4+ T cells

Zhang W. et al, (2003), Journal of Neuroimmunology, 139, 102 - 108

Monoclonal Antibody (MAB) to a complementary peptide for torpedo acetylcholine receptor (ACHR) residues61–76 recognizes idiotype antibodies (ID-ABS): Possible utility in Myasthenia Gravis (MG)

Araga S. et al, (1994), Journal of Neuroimmunology, 54, 150 - 150

Include forthcoming?